共 38 条
- [1] Fliedner S.M.J., Brabant G., Lehnert H., Pheochromocytoma and paraganglioma: genotype versus anatomic location as determinants of tumor phenotype, Cell Tissue Res, 372, 2, pp. 347-365, (2018)
- [2] Lam A.K., Update on adrenal tumours in 2017 world health organization (WHO) of endocrine tumours, Endocr Pathol, 28, 3, pp. 213-227, (2017)
- [3] Farrugia F.A., Charalampopoulos A., Pheochromocytoma, Endocr Regul, 53, 3, pp. 191-212, (2019)
- [4] Parasiliti-Caprino M., Lucatello B., Lopez C., Et al., Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy, Hypertens Res, 43, 6, pp. 500-510, (2020)
- [5] Schovanek J., Martucci V., Wesley R., Et al., The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study, BMC Cancer, 14, (2014)
- [6] Cui Y., Ma X., Gao Y., Et al., Local-Regional recurrence of pheochromocytoma/paraganglioma: characteristics, risk factors and outcomes, Front Endocrinol (Lausanne), 12, (2021)
- [7] Moog S., Castinetti F., DoCao C., Et al., Recurrence-Free survival analysis in locally advanced pheochromocytoma: first appraisal, J Clin Endocrinol Metab, 106, 9, pp. 2726-2737, (2021)
- [8] Dhir M., Li W., Hogg M.E., Et al., Clinical predictors of malignancy in patients with pheochromocytoma and paraganglioma, Ann Surg Oncol, 24, 12, pp. 3624-3630, (2017)
- [9] Liu Z., Ma J., Jimenez C., Zhang M., Pheochromocytoma, A clinicopathologic and molecular study of 390 cases from a single center, Am J Surg Pathol, 45, 9, pp. 1155-1165, (2021)
- [10] Press D., Akyuz M., Dural C., Et al., Predictors of recurrence in pheochromocytoma, Surgery, 156, 6, pp. 1523-1528, (2014)